Empty
1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477.
PMID: 31504439
DOI: https://doi.org/10.1093/eurheartj/ehz425
2. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):e44-e164.
PMID: 23182125
DOI: https://doi.org/10.1016/j.jacc.2012.07.013
3. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, et al. Global epidemiology of ischemic heart disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7):e9349.
PMID: 32742886
DOI: 10.7759/cureus.9349
4. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.
PMID: 28886621
DOI: https://doi.org/10.1093/eurheartj/ehx393
5. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2014;64(24):e139-e228.
PMID: 25260716
DOI: https://doi.org/10.1016/j.jacc.2014.09.017
Background
Multifocal atrial tachycardia (MAT) is a supraventricular arrhythmia characterized by an irregular rhythm with varying P-wave morphologies, reflecting multiple ectopic atrial pacemaker sites. It is defined by the presence of three or more distinct P-wave morphologies on ECG, irregular R-R intervals, and an atrial rate usually between 100–150 beats per minute. MAT is most commonly associated with chronic pulmonary disease, especially in elderly patients with acute exacerbations of COPD.
I) Classification/Types
By Rhythm Regularity:
- Irregularly irregular rhythm with ≥3 distinct P-wave morphologies
- Sometimes confused with atrial fibrillation, but P waves are discrete and identifiable
By Underlying Etiology:
- Pulmonary-associated MAT (e.g., COPD, hypoxia)
- Metabolic-associated MAT (e.g., electrolyte disturbances, sepsis)
- Drug-induced MAT (e.g., theophylline, catecholamines)
Pathophysiology
MAT results from multiple areas of automatic atrial activity, typically triggered by underlying metabolic or pulmonary derangements. These multiple foci depolarize the atria independently, causing a disorganized yet non-reentrant rhythm. Enhanced automaticity from hypoxia, hypercapnia, or catecholamine excess plays a key role. Ventricular conduction is irregular, reducing cardiac efficiency.
Epidemiology
- Uncommon arrhythmia; often underdiagnosed
- Predominantly affects elderly patients with chronic cardiopulmonary disease
- Frequently seen in hospitalized or critically ill patients
- More prevalent in individuals with acute exacerbations of COPD
Etiology
I) Causes
- Exacerbations of COPD
- Hypoxia
- Pulmonary embolism
- Sepsis
- Heart failure
- Electrolyte disturbances (especially hypokalemia, hypomagnesemia)
- Drug toxicity (e.g., theophylline, digitalis, beta-agonists)
II) Risk Factors
- Advanced age
- Chronic pulmonary disease
- Systemic illness or ICU admission
- Recent surgery
- Theophylline or beta-agonist therapy
- Hypoxia or acid-base disturbances
Clinical Presentation
I) History (Symptoms)
- Palpitations
- Dyspnea
- Fatigue
- Chest discomfort
- Symptoms of underlying illness (e.g., COPD exacerbation, sepsis)
- May be asymptomatic and found incidentally
II) Physical Exam (Signs)
- Irregularly irregular pulse
- Tachycardia (HR typically 100–150 bpm)
- Signs of respiratory distress (e.g., wheezing, accessory muscle use)
- Hypoxia or signs of decompensated respiratory disease
- No flutter waves or regular pattern as in atrial flutter
Differential Diagnosis (DDx)
- Atrial fibrillation
- Atrial flutter with variable block
- Sinus tachycardia
- Ectopic atrial tachycardia
- AVNRT (inappropriate presentation)
- Ventricular tachycardia (if wide QRS)
Diagnostic Tests
Initial Work-Up
- ECG: Irregular rhythm with at least 3 distinct P-wave morphologies, variable P-R intervals, and isoelectric baseline between P waves
- Telemetry/Holter: For paroxysmal or persistent monitoring
- Arterial blood gas (ABG): Assess for hypoxia, hypercapnia
- Serum electrolytes: Especially potassium and magnesium
- Chest X-ray: Evaluate for COPD, infection, or CHF
- Echocardiography: Assess underlying cardiac function
- TSH, T4: Rule out thyroid disease
Treatment
I) Initial Approach
- Focus on treating the underlying cause
- Oxygen therapy for hypoxia
- Bronchodilators and steroids for COPD exacerbation
- Electrolyte repletion (K+, Mg2+)
- Rate control if symptomatic tachycardia persists
II) Medications
Drug Class | Examples | Notes |
Rate control | Verapamil (preferred), Metoprolol | Use caution in COPD; verapamil often better tolerated |
Electrolyte repletion | Potassium, Magnesium | Essential to suppress ectopic activity |
Bronchodilators | Albuterol, Ipratropium | Use cautiously; may worsen arrhythmia |
Avoid | Beta-agonists, Theophylline | Can exacerbate MAT |
Antiarrhythmics | Generally not effective | Not first-line unless refractory and severe |
Consults/Referrals
- Cardiology: If diagnosis uncertain or refractory case
- Pulmonology: For optimization of chronic lung disease
- Pharmacy: For medication reconciliation, especially avoiding theophylline toxicity
- Critical care: If patient is unstable or in ICU
Patient Education, Screening, Vaccines, Education
- Recognize symptoms of arrhythmia and underlying conditions
- Importance of medication and oxygen compliance
- Avoid medications known to precipitate MAT
- Manage and monitor chronic lung disease
Screening/Prevention
- Routine ECG in hospitalized or elderly patients with COPD
- Monitor for arrhythmias during acute illness
- Optimize pulmonary disease management to reduce risk
Vaccinations
- Influenza and pneumococcal vaccines
- COVID-19 vaccines as per guidelines
Follow-Up
Short-Term
- ECG monitoring during acute illness
- Serial labs for electrolytes
- Monitor oxygenation and respiratory parameters
Long-Term
- Manage and stabilize pulmonary disease
- Periodic reassessment of rhythm and symptom burden
- Holter monitoring in recurrent or unexplained palpitations
Prognosis
- MAT often resolves with correction of the underlying cause
- Recurrence likely if chronic lung disease remains poorly controlled
- Does not usually require long-term anticoagulation unless associated with AF
- Associated with poor prognosis in critically ill or elderly due to underlying illness, not the arrhythmia itself
